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Background: Although multiple sclerosis (MS) is thought to represent an excessive and inappropriate immune response to several central nervous system (CNS) autoantigens, increasing evidence also suggests that MS may also be a neurovascular inflammatory disease, characterized by endothelial activation and shedding of cell membrane microdomains known as 'microparticles' into the circulation.
Objective: To investigate the relationships between these endothelial biomarkers and MS. Conclusion: These results indicate that circulating microparticles' profiles in MS may support mechanistic roles for microvascular stress and injury which is an underlying contributor to not only MS initiation and progression, but also to pro-inflammatory responses.
Introduction.
Multiple sclerosis (MS) is a presumably immune-mediated neurovascular disease whose etiology is influenced by genetic, environmental and even hemodynamic factors Microparticles' (MP) are small (<0.1m) circulating remnants of endothelial, platelet and other immune cell membranes, which present an important new class of clinical biomarkers. The MP profile may foreshadow BBB failure 9, 6 and serve as 'surrogate' markers of vascular stress in MS. Importantly, MP carry endothelial adhesion molecules ('ECAMs'), apoptotic, and other molecular markers from their parent cells, which may link vascular activation to disease activity in MS. MP analysis, therefore, may represent a simple method to monitor MS activity and response to treatment. When correlated with specific brain MRI parameters, MPs can provide important mechanistic insights into MS initiation pathogenesis.
Several endothelial and platelet ECAMs have now been described as MP markers in MS including CD51/CD61 (V/3-integrin), CD31 (platelet endothelial cell adhesion molecule-1) 7 and CD54 (intercellular adhesion molecule-1/ICAM-1) 7 . CD31 is an immunoglobulin -superfamily ECAM constitutively expressed on apical and junctional endothelial surfaces, and on platelets, myeloid cells and lymphocytes. CD31 ; and appear to correlate with early changes in BBB disruption and axonal injury, often abating during remission and therapy 7 . Another MP marker, CD51 (integrin V) forms several complexes which bind fibronectin and vitronectin and regulates vascular structure and stability Comparisons of these MP markers in different forms of MS suggest MP may provide a means of evaluating and distinguishing MS subtypes, and potentially, measuring the therapeutic effectiveness of disease modifying drugs. Lastly, annexin-V binding to MP suggests that MP can reflect early stages of apoptosis and in conjunction with endothelial MPs annexin-V + , reveals inflammatory injury, and in this report, were studied as markers of cell stress and activation 6 . The present study correlated several circulating MP species in RRMS and SPMS (and healthy controls) with conventional and advanced MRI outcomes to evaluate this approach as a noninvasive metric for use by clinicians to assist in documentation of disease activity in MS.
Methods.
Subject identification and MS diagnosis. RRMS and SPMS patients and age-and sex-matched healthy controls (HC) were enrolled at the Department of Neurology, University of Buffalo, Buffalo, NY. Inclusion criteria were MS diagnosis according to McDonald criteria, 10 , RR or SP disease, 11 having an MRI exam performed 30 days of clinical examination with the standardized study protocol, age 18-80 years and EDSS = 0-8.5. Exclusion criteria included relapse/exacerbation or steroid treatment 30 days of study, pre-existing conditions associated with non-MS brain pathology or pregnancy. HC subjects were recruited from hospital personnel and respondents to local advertisements. HC underwent physical examination, and were assessed for demographic characteristics, autoimmune and other concomitant diseases, vascular and environmental risks and personal habits. Serum samples were stored -80C. Samples of serum were analyzed at Louisiana State University Health Science CenterShreveport (LSUHSC-S). The study was approved by Institutional Review Board at the University at Buffalo.
MP isolation, labeling, and flow cytometry analysis. Blood was drawn into serum collection tubes and sera removed and aliquots frozen at -80C. Serum samples were first centrifuged for 10 minutes (160xg) and then centrifuged for 6' minutes at 500 x g. Cleared supernatants from these spins were then centrifuged at 14,0000xg for Flow cytometry analysis was performed using CellQuest for data acquisition and data analysis. Species of MP defined by flow profiling are shown in Table I .
MRI analysis.
All scans were acquired on a 3T GE Signa Excite HD 12.0 TwinSpeed 8-channel scanner (General Electric 'GE', Milwaukee, WI, USA), with a maximum slew rate of 150T/m/s and maximum gradient amplitude in each orthogonal plane of 50 mT/m (zoom mode). A multi-channel head and neck (HDNV) coil (GE) was used to acquire the following sequences: 2D multiplanar dual fast spin-echo (FSE), proton density (PD) and T2-weighted image (WI); fluid-attenuated inversion-recovery (FLAIR); 3D high resolution (HIRES) T1-WI using a fast-spoiled gradient echo (FSPGR) with magnetization-prepared inversion recovery (IR) pulse; susceptibilityweighted imaging (SWI); and SE T1-WI both with and without a single dose intravenous bolus of 0.1 mM/Kg gadolinium (Gd)-DTPA (Gd-DTPA given only to MS subjects). All scans were prescribed in an axial-oblique orientation, parallel to the subcallosal line. One average was used for all pulse sequences. Other relevant parameters were as follows: for dual FSE PD/T2, echo and repetition times (TE and TR) TE1/TE2/TR=9/98/5300ms, flip angle (FA)=90o, echo train length ETL=14; for FLAIR, TE/TI/TR=120/2100/8500 ms (inversion time, IT), FA=90o, ETL=24; for SE T1-WI, TE/TR=16/600 ms, FA=90; for 3D HIRES T1-WI, TE/TI/TR=2.8/900/5.9 ms, FA=10o.
All analyses were performed by operators blinded to participants' disease status. SWI was acquired using a 3D flow-compensated gradient echo (GRE) sequence with 64 partitions, 2mm thickness, a 512x192 matrix, Global atrophy and lesion analyses. The SIENAX cross-sectional software tool (version 2.6) was used, with correction for T1-hypointensity misclassification, for brain extraction and tissue segmentation on 3D-T1-WI
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.
We acquired normalized measures of whole brain volumes (NBV), gray matter volumes (NGMV) and white matter volumes (NWMV). T2-and T1-lesion volumes (LV) were measured on FLAIR and SE T1-WI, respectively, using a semi-automated edge detection contouring/thresholding technique, (previously Abnormal phase identification. SDGM structures were segmented using a combination of semi-automated edge-contouring and FIRST on 3D T1-WI 15 . The thalamus, caudate, putamen, globus pallidus, hippocampus, amygdala, and nucleus accumbens were identified using this approach. 14 Structures not identifiable by FIRST, (red nucleus, pulvinar nucleus of the thalamus, substantia nigra, were identified semi-automatically using JIM5 (Xinapse Systems, Northamptonshire, UK) on the most representative slice for each subject 14 Using these methods, it has been determined that segmentation of separate SDGM regions can be reliably reproduced 12 .
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A detailed overview of SWI processing, reproducibility and analysis methods has been previously described 12 . Briefly, using SWI-filtered phase images, processing was performed to identify voxels likely to contain iron, based on their mean phase values. Images were thresholded to retain only voxels with phase values 2SDs below the reference mean-values of each structure. As a measure of the degree of phase decrease, mean values of sub-threshold voxels of the mean phase of low phase voxels (MP-LPV) were calculated. More negative (decreased) MP-LPV values suggest increased regional iron content. Mean values are presented in radians.
Statistical analysis. We analyzed correlations between MRI and MPs using the SPSS 11.5 statistical package (SSPS Inc. Chicago, IL). Quantitative data are presented as mean±SD or median. Data were compared by 2-tailed t-test and non-parametric Mann-Whitney U-testing between groups. Data are expressed as rate and compared by X 2 test. Pearson or Spearman-correlation analyses were conducted for variables with trends towards correlation.
Multivariate-linear regressions were adopted for multiple factor analysis. A p< 0.05 was considered statistically significant.
Results.
Demographic, clinical and MRI characteristics of participants.
44 patients with RRMS, 16 with SPMS, and 36 healthy controls (HC) participated in the study. Study subjects with MS had a mean age of 48.1 years (± SD=10.6, median 50), at study entry, with mean disease duration of 139.2 months (RRMS) and 277.2 months (SPMS). The mean age of HC subjects was 42.8±12.7 (SD) years (median=47). 45 MS patients were female and 15 were male. Demographic features are presented in Table 2 .
Different MP types identified. Several different MP types were identified in this study based on their surface expression of CD31 (PECAM-1), CD51/61 (integrin αV/3) and CD54 (ICAM-1) (shown in Table 1 Elevated iron in the caudate and globus pallidus has been previously reported in Alzheimer's disease 19 , and in the caudate (and putamen) in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 20 .
In healthy controls, some significant negative associations between tissue iron loading and microparticle species were also observed. While not certain, these data suggest that these MP may be associated with iron 
RRMS.
In RRMS, several interesting relationships were observed between circulating microparticles and iron content in several brain regions. Table 5 
